Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV16+ Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04852328
What this trial is testing

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Washington University School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT04398524
What this trial is testing

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
ISA Pharmaceuticals 65
Testing effectiveness (Phase 2)Study completedNCT04180215
What this trial is testing

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Hookipa Biotech GmbH 198
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07418034
What this trial is testing

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CancerHead and Neck Squamous Cell Carcinoma+11 more
University of Maryland, Baltimore 132
Early research (Phase 1)Looking for participantsNCT06589609
What this trial is testing

Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (SCC)
BlueSky Immunotherapies GmbH 12
Testing effectiveness (Phase 2)Study completedNCT02858310
What this trial is testing

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Who this might be right for
Papillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more
National Cancer Institute (NCI) 224
Early research (Phase 1)Study completedNCT03978689
What this trial is testing

Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaHPV-Related Carcinoma
Cue Biopharma 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205
What this trial is testing

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Who this might be right for
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE 358
Early research (Phase 1)Looking for participantsNCT07081984
What this trial is testing

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Who this might be right for
HPV 16+ Recurrent or Metastatic CancerHNSCCCervical Cancer
Therorna 12
Early research (Phase 1)Study completedNCT00019110
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

Who this might be right for
Anal CancerCervical CancerEsophageal Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05582122
What this trial is testing

SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers

Who this might be right for
Oropharynx Squamous Cell Carcinoma
UNICANCER 420
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996523
What this trial is testing

Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (SCC)
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Looking for participantsNCT07209189
What this trial is testing

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 75
Testing effectiveness (Phase 2)WithdrawnNCT04001413
What this trial is testing

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerHPV-Related Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Active Not RecruitingNCT03260023
What this trial is testing

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Who this might be right for
HPV-Related CarcinomaHPV-Related Cervical CarcinomaHPV-Related Anal Squamous Cell Carcinoma+2 more
Transgene 143
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Testing effectiveness (Phase 2)Looking for participantsNCT07172256
What this trial is testing

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaNew Diagnosis Tumor+1 more
Yale University 30
Not applicableStudy completedNCT03226613
What this trial is testing

New Modalities for Detection of Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerBase of Tongue Carcinoma+1 more
Vanderbilt University Medical Center 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06505551
What this trial is testing

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

Who this might be right for
HPV-Related Squamous Cell CarcinomaHPV-Related Cervical Squamous Cell CarcinomaHPV-Related Vulvar Squamous Cell Carcinoma+4 more
SCG Cell Therapy Pte. Ltd. 66
Large-scale testing (Phase 3)Ended earlyNCT06790966
What this trial is testing

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more
PDS Biotechnology Corp. 12
Next Page